Previous studies have indicated that XPD-Gln751 variant was associated with several cancers, namely chronic myeloid leukaemia (CML) [51], oesophageal squamous cell carcinoma [52], digestive tract cancer [52], and hepatocellular carcinoma [53]. Here, ERCC2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.